We are developing cutting-edge, AI-based medical applications, that will revolutionize the field of neuroscience and lead to improved patient outcomes.


Read more

Product

In real-life clinical practice, Sigmund AI™️ optimizes the treatment of central nervous system disorders. With Sigmund AI™️ clinicians can leverage the proven benefits of objective machine learning based anatomical segmentation, analytics and intelligent guidance, significantly reducing (and eventually eliminating) the need for traditional, time consuming non-objective image analytics performed by doctors. This reduces the potential for errors, optimizes workflows, and reduces cognitive load while freeing the clinician to focus on higher level tasks.


Read more

About the Company

Inteneural Networks Inc. is a Chicago-based medical high-tech company, specializing in Artificial Intelligence and Big Data Learning analysis of brain imaging.

It was founded in 2017 by experienced scientists and high-tech investors: A pioneer in Data Mining and Big Data Learning – Professor Paul Lewicki PhD and a neuro-surgeon who specializes in high-tech spine diagnostic and surgical applications - Kris Siemionow MD, PhD. The headquarters and one R&D center are located in the US (Chicago), the other R&D center is in Poland (Poznan).


Read more

Advantages


  • Intenerual uses advanced AI-machine learning algorithms to compare users’ brain MRIs to a large database (approximately 10,000 and growing) of healthy brain scans and brain scans of patients who suffer from disorders identified by doctors in individual, in-depth analyses.

  • Combinations of wide varieties of scientifically validated biomarkers are assessed using AI-segmentation (e.g., lateral ventricle to whole brain ratios, symmetricity of brain hemispheres, volumetric data and shape of hippocampus).

  • In minutes, users can find out their “brain health,” their “brain age”, presence or absence of findings commonly associated with dementia or Alzheimer’s, any indications of brain injury (high blood pressure, presence/absence of primary tumor or aneurysm). All of these indices strongly correlate with wellbeing and general health.

    As a bonus, INN application assesses cognitive performance capability.

News

  1. Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences, JUN 07, 2021

    https://www.surgalign.com/news/surgalign-holdings-announces-collaboration-with-inteneural-networks-a-leading-developer-of-artificial-intelligence-for-clinical-neurosciences/

  2. Comparing methods of detecting and segmenting unruptured intracranial aneurysms on TOF-MRAS: The ADAM Challenge - ScienceDirect, NeuroImage, Volume 238, September 2021, 118216

    https://www.sciencedirect.com/science/article/pii/S1053811921004936

  3. Photon Challenge: PREDICTIVE ANALYTICS COMPETITION 2019. Inteneural scored a top place in the challenge by developing a model.

    https://www.sciencedirect.com/science/article/pii/S1053811921004936

Headquarters:

Inteneural Networks Inc.
835 S. Wolcott Ave,
Chicago, IL 60612, U.S.A.


E-mail:

info@inteneural.com